Spinal Tech

Researchers at the University of New South Wales in Australia are developing and testing the Thru-Fuze device to promote bone growth during spinal fusion, according to a HospiMedica report.

Zacks upgraded Exactech from a "sell" rating to a "strong buy" rating, according to a Dakota Financial News report.

Orchid Orthopedic Solutions has completed its acquisition of the Cam Bioceramics' coating facility and operations in China.

Here are 13 key notes on orthopedic and spine device companies over the past week.

Instratek launched its ToeTac implant.

Checkpoint Surgical has closed its first round of financing, according to a Mass Device report.

Stryker Director Ronda E. Stryker has sold 18,000 shares in a recent transaction, according to a Dakota Financial News report.

SeaSpine signed a three-year credit facility with Wells Fargo Capital Finance.

An Ohio judge ruled accusations against Stryker's CerviCore available earlier this month.

AlloSource has received a patent for its regenerative medicine product AlloStem Cellular Bone Allograft.